Cordlife Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Cordlife Group şirketinin kazançları yıllık ortalama -24.9% oranında azalırken, Healthcare sektörünün kazançları yıllık 5.8% oranında artan oldu. Gelirler yıllık ortalama 4.3% oranında azalan oldu.

Anahtar bilgiler

-24.9%

Kazanç büyüme oranı

-25.0%

EPS büyüme oranı

Healthcare Sektör Büyümesi	9.7%
Gelir büyüme oranı	-4.3%
Özkaynak getirisi	-9.0%
Net Marj	-30.2%
Son Kazanç Güncellemesi	30 Jun 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

May 06

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

Mar 22

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

Sep 07

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

Aug 02

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Apr 03

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Oct 15

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Aug 22

Gelir ve Gider Dağılımı

Cordlife Group nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

SGX:P8A Gelir, gider ve kazançlar (SGD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Jun 24	37	-11	37
31 Mar 24	46	-4	38
31 Dec 23	56	4	38
30 Sep 23	56	4	38
30 Jun 23	57	5	38
31 Mar 23	56	5	37
31 Dec 22	55	5	36
30 Sep 22	55	5	36
30 Jun 22	56	6	35
31 Mar 22	56	6	36
31 Dec 21	57	6	36
30 Sep 21	58	6	36
30 Jun 21	60	6	37
31 Mar 21	60	6	37
31 Dec 20	59	7	38
30 Sep 20	59	8	39
30 Jun 20	58	7	41
31 Mar 20	58	7	42
31 Dec 19	62	6	43
30 Sep 19	60	3	43
30 Jun 19	59	2	43
31 Mar 19	69	4	43
31 Dec 18	60	2	44
30 Jun 18	68	3	43
31 Mar 18	67	3	42
31 Dec 17	62	-1	40
30 Sep 17	62	-1	40
30 Jun 17	60	-3	39
31 Mar 17	60	-6	41
31 Dec 16	60	-7	40
30 Sep 16	60	4	39
30 Jun 16	60	12	38
31 Mar 16	60	36	37
31 Dec 15	59	56	36
30 Sep 15	59	43	36
30 Jun 15	58	32	35
31 Mar 15	56	28	32
31 Dec 14	53	11	31
30 Sep 14	51	18	29
30 Jun 14	49	31	27
31 Mar 14	45	18	25
31 Dec 13	40	18	23

Kaliteli Kazançlar: P8A şu anda kârlı değil.

Büyüyen Kar Marjı: P8A şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: P8A kârlı değildir ve zararlar son 5 yılda yılda 24.9% oranında artmıştır.

Büyüme Hızlandırma: P8A 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: P8A kârlı olmadığından, geçmiş yıl kazanç büyümesinin Healthcare sektörüyle ( -26% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: P8A hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -8.95% ) sahiptir.

Cordlife Group Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

Full year 2023 earnings released: EPS: S$0.015 (vs S$0.019 in FY 2022)

First half 2023 earnings released: EPS: S$0.009 (vs S$0.007 in 1H 2022)

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Cordlife Group Limited to Report Q1, 2023 Results on Nov 24, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Recent updates

Cordlife Group Limited Appoints Gao Xiang as Independent Non-Executive Director, Effective 14 November 2024 and Chairman of Audit and Risk Committee, Effective 30 November 2024

Cordlife Group Limited Announces Change of Joint Company Secretaries

Cordlife Group Limited Announces Cessation of Tan Huiying as Group Director, Quality and Operations, Effective 4 November 2024

Cordlife Group Limited Announces Re-Designation of Chen Xiaoling from Non-Independent Non-Executive Director to Group Executive Director

High number of new and inexperienced directors

Cordlife Group Limited Announces Changes to the Composition of Board and the Board Composition

Cordlife Group Limited Announces Retirement of Cheong Tuck Yan Titus Jim as Independent Director

Cordlife Group Limited Announces the Appointment of Dato' Dr. Teo Tong Kooi as Independent Non-Executive Director, Effective May 14, 2024

Cordlife Group Limited Announces Directors Removal

Cordlife Group Limited (SGX:P8A) Looks Inexpensive After Falling 30% But Perhaps Not Attractive Enough

Cordlife Group Limited Announces Board Changes

Cordlife Group Limited Announces Board Resignations

New minor risk - Share price stability

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Cordlife Group Limited has filed a Follow-on Equity Offering in the amount of SGD 8.191276 million.

Risks Still Elevated At These Prices As Cordlife Group Limited (SGX:P8A) Shares Dive 31%

New minor risk - Financial data availability

Full year 2023 earnings released: EPS: S$0.015 (vs S$0.019 in FY 2022)

Cordlife Group Limited Announces Changes in the Composition of the Board and Board Committees

New minor risk - Financial data availability

Cordlife Group Limited Announces the Cessation of Tan Poh Lan as Executive Director

Now 34% undervalued after recent price drop

Cordlife Group Limited Announces Resignation of Ms. Tan Poh Lan as a Group Chief Executive Officer, Effective 31 March 2024

Estimating The Fair Value Of Cordlife Group Limited (SGX:P8A)

New minor risk - Earnings quality

First half 2023 earnings released: EPS: S$0.009 (vs S$0.007 in 1H 2022)

Cordlife Group (SGX:P8A) Will Be Hoping To Turn Its Returns On Capital Around

New minor risk - Market cap size

Cordlife Group Limited Announces Change of Company Secretary

Cordlife Group Limited Announces Resignation of Kuan Yoke Kay as the Joint Company Secretary

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Cordlife Group (SGX:P8A) Might Be Having Difficulty Using Its Capital Effectively

Full year 2022 earnings released: EPS: S$0.019 (vs S$0.024 in FY 2021)

Now 20% undervalued after recent price drop

Cordlife Group Limited Appoints that Hnin Yi as Group Chief Financial Officer

Now 20% undervalued after recent price drop

Now 28% undervalued after recent price drop

High number of new directors

Cordlife Group Limited to Report Q1, 2023 Results on Nov 24, 2022

Cordlife Group (SGX:P8A) Is Looking To Continue Growing Its Returns On Capital

Cordlife Group Limited Announces Resignation of Choo Boon Yong as Group Chief Financial Officer

High number of new directors

Cordlife Group Limited Approves Final Tax Exempt (1-Tier) Dividend for the Financial Year Ended 31 December 2021

High number of new directors

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Proposes Final Tax Exempt Dividend for the Year Ended December 31, 2021, Payable on May 27, 2022

Full year 2021 earnings: EPS exceeds analyst expectations while revenues lag behind

Cordlife Group Limited Appoints Kuan Yoke Kay as the Joint Company Secretary

High number of new directors

Non-Independent Non-Executive Director Lin Wang has left the company

Cordlife Group's (SGX:P8A) Problems Go Beyond Weak Profit

Cordlife Group Limited Approves Final Dividend for the Financial Year Ended 31 December 2020, Payable on 28 May 2021

Cordlife Group Limited Announces the Launch of OptiQ

Global Cord Blood Corporation (NYSE:CO) cancelled the acquisition of Cordlife Group Limited (SGX:P8A) in a reverse merger transaction.

New 90-day high: S$0.40

Cordlife Group Limited Announces Resignation of Goh Jin Hian from the Position of Independent Director

First half earnings released

New 90-day high - S$0.40

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin